Title : LncRNA H19 downregulation confers erlotinib resistance through upregulation of PKM2 and phosphorylation of AKT in EGFR-mutant lung cancers.

Pub. Date : 2020 Aug 28

PMID : 32439420






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 LncRNA H19 downregulation confers erlotinib resistance through upregulation of PKM2 and phosphorylation of AKT in EGFR-mutant lung cancers. Erlotinib Hydrochloride H19 imprinted maternally expressed transcript Homo sapiens
2 H19 downregulation contributed to erlotinib resistance through interaction and upregulation of PKM2, which enhanced the phosphorylation of AKT. Erlotinib Hydrochloride H19 imprinted maternally expressed transcript Homo sapiens
3 These findings revealed a novel mechanism of low-level H19 in the regulation of erlotinib resistance in EGFR-mutant lung cancers. Erlotinib Hydrochloride H19 imprinted maternally expressed transcript Homo sapiens